Poolbeg Pharma Share News (POLB)

EARNINGS AND TRADING: Kingswood cuts outlook; Poolbeg in patent joy

(Alliance News) - The following is a round-up of updates by London-listed companies, issued last week and not separately reported by Alliance News:

TRADING UPDATES: Braemar investigation to end; Marula reports delay

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday, Thursday and Wednesday and not separately reported by Alliance News:

Poolbeg gets notice of a new Japan patent

(Sharecast News) - Clinical-stage biopharmaceutical company Poolbeg Pharma announced the receipt of a notice of allowance from the Japanese Patent Office for its Immunomodulator I patent application on Wednesday.

TRADING UPDATES: Chill Brands unphased by regulations; Cobra inks deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

EARNINGS: Frontier Developments turns to loss; Poolbeg optimistic

(Alliance News) - The following is a round-up of earnings of London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Poolbeg Pharma makes "significant" influenza breakthrough with AI

(Alliance News) - Poolbeg Pharma PLC on Thursday said it has made a significant breakthrough in its "world-first" influenza artificial intelligence programme with CytoReason Ltd.

Poolbeg reports progress with oral vaccine development

(Sharecast News) - Clinical-stage biopharmaceutical company Poolbeg Pharma updated the market on its oral vaccine programme on Thursday.

IN BRIEF: Poolbeg oral vaccination programme moves forward

Poolbeg Pharma PLC - London-based infectious disease focused biopharmaceutical company - Says oral vaccine programme is moving forward to encapsulation validation process. Expects validation to be completed in the second half of 2023. Back in November, Poolbeg's consortium EncOvac received funding of EUR2.3 million from the Irish government to improve the manufacturing, distribution and administration of its oral vaccines. Poolbeg is collaborating with University College Dublin, Trinity College Dublin and AnaBio Technologies over three years to develop an oral vaccine candidate to a phase 1 ready state.

UK shareholder meetings calendar - next 7 days

TRADING UPDATES: Poolbeg patent boost; Resolute Mining resource up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and Tuesday not separately reported by Alliance News:

TRADING UPDATES: Cordiant Digital hails portfolio firm's deal with AMC

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

AIM WINNERS & LOSERS: Metal Tiger goes into the Strata but out of AIM

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

TRADING UPDATES: Tungsten West 'largest Western tungsten producer'

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Poolbeg expands its focus molecule into oncology

(Sharecast News) - Poolbeg Pharma announced the strategic expansion of 'POLB 001' into oncology on Monday.

Poolbeg Pharma says initial POLB 001 data shows positive response

(Alliance News) - Poolbeg Pharma PLC on Monday said initial data analysis in its POLB 001 LPS challenge trial indicated a clear anti-inflammatory response.